XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1

ACCRUED LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Schedule of accrued liabilities

Accrued liabilities consisted of the following as of March 31, 2023 and December 31, 2022:

		MARCH 31,				DECEMBER 31,
(In thousands)		2023				2022
CRO and clinical trial costs		$	18,863			$	17,040
Manufacturing activities			4,335				5,321
Legal settlements			8,350				8,350
Professional legal and accounting fees			898				1,318
Interest payable			585				561
Other			1,660				510
		$	34,691			$	33,100

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration